AstraZeneca Secures Global Rights to GPC3 CAR-T Therapy
Rockville, Md. and Shanghai, January 18, 2026 — AbelZeta Pharma, Inc. announced that AstraZeneca has agreed to acquire AbelZeta’s...
Cell and Gene Therapy
Advertisement
FDA Expands Regulatory Flexibility for Cell and Gene Therapies
White Oak, Maryland – January 2026 — The U.S. Food and Drug Administration has announced a more flexible regulatory...
Veru Advances Enobosarm Program with FDA Clarity in Obesity
MIAMI, Fla., December 17, 2025 — Veru Inc., a late-stage biopharmaceutical company, reported its fiscal year 2025 financial results...
uBriGene Launches GMP LVV Turbo Platform with UltraCell Integration
CAMBRIDGE, Massachusetts, December 17, 2025 — uBriGene, a leader in advanced biopharmaceutical manufacturing, has launched LVV Turbo™, its next-generation...
McKesson Expands Cell and Gene Therapy Access Across the U.S.
IRVING, Texas, Oct. 6, 2025 — McKesson Corporation has released new insights highlighting the rapid growth and expanding infrastructure...
Advertisements
Next-Generation Cell Isolation Partnership Expands Global Access to Gene Therapy Tools
ANN ARBOR, Mich., September 25, 2025 — Cayman Chemical, a global provider of life science research tools, and Akadeum...
Advertisement
